Biomarkers for prognosis in critically ill COVID-19 patients : a prospective cohort study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21322

Enrollment

100

Registered

2020-03-16

Start date

2020-03-16

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower respiratory tract infections

Interventions

During routine daily laboratory rounds blood will be stored at -80 C until biomarkers will be assayed later.

Eligibility

Inclusion criteria

Inclusion criteria: SARS-CoV 2 PCR positive patients at the intensive care

Exclusion criteria

Exclusion criteria: SARS-CoV 2 PCR negative OR no SARS-CoV 2 PCR

Design outcomes

Primary

Measure	Time frame
28-day mortality	—

Secondary

Measure	Time frame
90-day mortality, ICU and hospital LOS, time on the ventilator	—

Contacts

Public ContactJAH VAN Oers

Elisabeth Tweesteden Ziekenhuis

jah.vanoers@etz.nl0132213808

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)